格林作为慢性炎症疾病的治疗点的潜力:来自人类子宫内膜 stromal 细胞的证据
Wenhui Dong1, Hongkai Mu2, Fan Jia3
1Medical Imaging Department, Shanxi Medical University, Taiyuan, China.
Frontiers in endocrinology
|September 17, 2025
概括
发现林是一种类激素,通过减少促炎细胞因子和增加抗炎细胞因子,促进人类子宫内膜层细胞生长并减少炎症. 这表明格林林激素.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
背景情况:
- 格林林是一种调节食欲和能量平衡的类激素.
- 格林还起到免疫调节剂的作用,影响慢性炎症中的免疫反应.
- 这项研究研究了格林对人类子宫内膜层细胞 (hEM15A) 和炎症的影响.
研究的目的:
- 为了确定格林对hEM15A细胞活性的影响.
- 分析格林对促炎和抗炎细胞因子的调节.
- 探索格林作为治疗炎症疾病的治疗剂的潜力.
主要方法:
- 治疗hEM15A细胞时使用不同度的 ghrelin.
- 使用细胞计数工具-8 (CCK-8) 试验评估了细胞活力.
- 细胞因子水平 (TNF-α,IL-6,IL-10) 通过ELISA测量,用西部斑块测量 ghrelin受体表达.
主要成果:
- 格林林受体 (GHSR) 在hEM15A细胞中成功表达.
- 格雷林增强了细胞增殖,特别是在更高的度下,而不会影响生命力.
- 格林显著降低了TNF-α和IL-6水平,同时以剂量依赖的方式增加了IL-10.
结论:
- 格林素促进细胞生长,通过通过其受体GHSR调节炎症,表现出保护作用.
- 格林在子宫内膜异位症的背景下显示出抗炎性质.
- 格雷林具有作为治疗策略的潜力,用于治疗慢性炎症状况,如子宫内膜异位症.
相关概念视频
Glucagon-like Receptor Agonists
850
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
850
Hormonal Regulation
47.8K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
47.8K


